Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenUG3Clinical trial: Optional / allowed

Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-25-296

Source: Grants.gov · View original posting ↗

Award
Up to $650K
Deadline
Oct 19, 2027
Letter of intent
Mechanism
UG3
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Dec 11, 2024
Total funding
$650K total
Clinical trial
Optional / allowed
Higher educationGovernmentForeign entities

Research areas

Therapeutics & drug discovery

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for all people more quickly.

Data notes: administering NIH institute could not be identified from the opportunity number.